Kalkofen Donald A. 4
4 · Protagonist Therapeutics, Inc · Filed Feb 26, 2021
Insider Transaction Report
Form 4
Kalkofen Donald A.
Chief Financial Officer
Transactions
- Award
Common Stock
2021-02-26+7,500→ 10,386 total - Award
Stock Option (right to buy)
2021-02-26+55,000→ 55,000 totalExercise: $23.57Exp: 2031-02-25→ Common Stock (55,000 underlying)
Footnotes (3)
- [F1]Represents grant of restricted stock units payable solely in common stock that will become fully vested on February 26, 2024.
- [F2]Includes an aggregate of 1,711 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2020 and September 9, 2020.
- [F3]The stock option vests in 48 equal monthly installments following the date of grant.